Galanin is a hyperpolarizing, inhibitory neurotransmitter; its recogni
tion by seven transmembrane spanning G-protein-coupled receptors leads
to a change in accumulation of cAMP (3'5'-cyclic AMP). Different subt
ypes of galanin receptor and G-proteins could be manifested in the mod
e of inhibitory action of galanin receptor on the production of cAMP b
y adenylate cyclase. Galanin analogues, acting at the adenylate cyclas
e level as subtype-specific galanin antagonists, can selectively block
the inhibitory effect of endogenous galanin and thereby have potentia
l as therapeutic agents for several endocrine, neuroendocrine and neur
onal disorders. In this review, the latest results in the field of int
erplay between galanin-initiated signal transduction and the cAMP path
way are summarized.